GAO “High-Risk List” Urges Enhanced FDA Oversight Of Medical Products
This article was originally published in The Gray Sheet
Executive Summary
The Government Accountability Office added enhanced oversight of devices, drugs and other medical products to its list of "high-risk" priorities in a report to Congress released Jan. 22